Aug 22 (Reuters) - The U.S. Food and Drug Administration

has approved updated COVID-19 vaccines made by Pfizer ( PFE )

and Moderna ( MRNA ) targeting newer variants of the disease in

time for a fall vaccination campaign, the agency said on

Thursday.

The regulator has approved the vaccines to target a variant

known as "KP.2", which dominated infections in recent months,

for individuals aged 12 years and above.